ALEHT Share Price

Open 0.30 Change Price %
High 0.31 1 Day 0.02 6.90
Low 0.30 1 Week 0.01 3.33
Close 0.31 1 Month 0.00 0.00
Volume 312498 1 Year -0.08 -20.51
52 Week High 0.40
52 Week Low 0.22
ALEHT Important Levels
Resistance 2 0.32
Resistance 1 0.32
Pivot 0.31
Support 1 0.30
Support 2 0.30
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
BRS 12.00 0.00%
More..
EPA France Top Gainers Stocks
APAM 33.78 15.72%
APAM 33.78 15.72%
OXI 0.08 14.29%
OXI 0.08 14.29%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
GDMS 692.00 -10.00%
CIB 0.10 -9.09%
CIB 0.10 -9.09%
CIB 0.10 -9.09%
CIB 0.10 -9.09%
MLZAM 1.65 -8.33%
MLOLM 10.50 -7.98%
HBW 0.15 -6.25%
ALPHY 13.00 -4.90%
JXR 0.62 -4.62%
More..

Diaxonhit (EPA: ALEHT)

ALEHT Technical Analysis 3
As on 16th Aug 2017 ALEHT Share Price closed @ 0.31 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.29 & Buy for SHORT-TERM with Stoploss of 0.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
ALEHT Target for August
1st Target up-side 0.33
2nd Target up-side 0.35
3rd Target up-side 0.37
1st Target down-side 0.27
2nd Target down-side 0.25
3rd Target down-side 0.23
ALEHT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.exonhit.com
ALEHT Address
ALEHT
65 Boulevard Mass
Paris, 75013
France
Phone: 33 1 53 94 77 00
Fax: 33 1 53 94 77 07
ALEHT Latest News
Interactive Technical Analysis Chart Diaxonhit ( ALEHT EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Diaxonhit
ALEHT Business Profile
Diaxonhit is engaged in the discovery and commercialization of in-vitro diagnostic products in transplantation, infectious diseases, and cancer diagnosis specialty areas. It markets a proprietary test, Tetanus Quick Stick, used in emergency clinics for the evaluation of the protective status of a patient against tetanus. The company's in-house development products include the BJI InoPlex kit, a test that allows the detection of infections linked to articular prosthesis; and EHT Dx15, a test for the diagnosis of thyroid cancer, as well as licensed product comprises AlloMap, a gene-expression profiling based blood test for regular and non-invasive surveillance of heart transplant recipients for acute cellular rejection. It is also developing companion diagnostics for resistant and breast cancers; and tests to monitor the direct effect of drug activity. The company was formerly known as Exonhit S.A. and changed its name to Diaxonhit in December 2012. Diaxonhit was founded in 1997 and is headquartered in Paris, France.